<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940523-0-00048</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=84 g=1 f=1 --> VIII. Objections  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any person who will be adversely affected by this regulation may at any time on or before June 22, 1994, file with the Dockets Management Branch (address above) written objections thereto. Each objection shall be separately numbered, and each numbered objection shall specify with particularity the provisions of the regulation to which objection is made and the grounds for the objection. Each numbered objection on which a hearing is requested shall specifically so state. Failure to request a hearing for any particular objection shall constitute a waiver of the right to a hearing on that objection. Each numbered objection for which a hearing is requested shall include a detailed description and analysis of the specific factual information intended to be presented in support of the objection in the event that a hearing is held. Failure to include such a description and analysis for any particular objection shall constitute a waiver of the right to a hearing on the objection. Three copies of all documents shall be submitted and shall be identified with the docket number found in brackets in the heading of this document. Any objections received in response to the regulation may be seen in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> IX. References  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The following references have been placed on display in the Dockets Management Branch (address above) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday.  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1. Transcript of meeting of the Food Advisory Committee, FDA, Herndon, VA, April 6 through 8, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Hoskins, L.C., ``Host and Microbial DNA in the Gut Lumen,'' The Journal of Infectious Diseases, 137:694&hyph;698, 1978.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Memorandum from T.A. Cebula, FDA, to N. Beru, FDA, November 2, 1993.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4. Potrykus, I., ``Gene Transfer to Plants: Assessment of Published Approaches and Results,'' in ``Annual Review of Plant Physiology and Plant Molecular Biology,'' Briggs, W.R., R.L. Jones, and V. Walbot, 42:205&hyph;225, 1991.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 5. Fraley, R.T. et al., ``Genetic Transformation in Higher Plants,'' Critical Reviews in Plant Sciences, 4:1&hyph;46, 1985.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 6. Beck, E. et al., ``Nucleotide Sequence and Exact Localization of the Neomycin Phosphotransferase Gene From Transposon Tn <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=5 f=3 --> 5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> ,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Gene,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 19:327&hyph;336, 1982.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 7. Jorgensen, R.A. et al., ``A Restriction Enzyme Cleavage Map of Tn <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=5 f=3 --> 5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  and Location of a Region Encoding Neomycin Resistance,'' Molecular and General Genetics, 177:65&hyph;72, 1979.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 8. Davies, J. et al., ``Plasmid-determined Resistance to Antimicrobial Agents,'' Annual Review of Microbiology, 32:469&hyph;518, 1978.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 9. Goldman, P.R. et al., ``Purification and Spectrophotometric Assay of Neomycin Phosphotransferase II,'' Biochemical and Biophysical Research Communications, 69:230&hyph;236, 1976.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 10. U.S. Pharmacopeia (U.S.P.), The National Formulary (NF) 1990, U.S.P. XXII, NF XVII, U.S. Pharmacopeial Convention, Inc., Mack Printing Co., Easton, PA.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 11. Prescott, J.F., and J.D. Baggot, ``Aminoglycosides and Aminocyclitols,'' in Antimicrobial Therapy in Veterinary Medicine, Blackwell Scientific Publications, Boston, MA, pp. 121&hyph;152, 1988.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 12. Davies, J.E., ``Aminoglycoside-aminocyclitol Antibiotics and Their Modifying Enzymes,'' in ``Antibiotics in Laboratory Medicine,'' 2d ed., Lorian, V., editor, pp. 790&hyph;809, 1986.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 13. Dickie, P. et al., ``Effect of Enzymatic Adenylation on Dihydrostreptomycin Accumulation in  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Escherichia coli  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Carrying the R-factor: Model Explaining Aminoglycoside Resistance by Inactivating Mechanisms,'' Antimicrobial Agents and Chemotherapy, 14:569&hyph;580, 1978.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 14. Nap, J.P et al., ``Biosafety of Kanamycin-resistant Transgenic Plants,'' Transgenic Research, 1:239&hyph;249, 1992.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            